Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Lyell Immunopharma Q2 Adj $(0.18) Beats $(0.20) Estimate, Sales $13.00K Down From $27.00K YoY

Author: Benzinga Newsdesk | August 07, 2024 05:17pm
Lyell Immunopharma (NASDAQ:LYEL) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 350 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $13.00 thousand in sales this quarter. This is a 51.85 percent decrease over sales of $27.00 thousand the same period last year.

Posted In: LYEL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist